Intravitreal aflibercept for proliferative diabetic retinopathy
- PMID: 29143753
- DOI: 10.1016/S0140-6736(17)32445-5
Intravitreal aflibercept for proliferative diabetic retinopathy
Comment in
-
Intravitreal aflibercept for proliferative diabetic retinopathy - Authors' reply.Lancet. 2017 Nov 11;390(10108):2141-2142. doi: 10.1016/S0140-6736(17)32422-4. Epub 2017 Nov 9. Lancet. 2017. PMID: 29143752 No abstract available.
Comment on
-
Clinical efficacy of intravitreal aflibercept versus panretinal photocoagulation for best corrected visual acuity in patients with proliferative diabetic retinopathy at 52 weeks (CLARITY): a multicentre, single-blinded, randomised, controlled, phase 2b, non-inferiority trial.Lancet. 2017 Jun 3;389(10085):2193-2203. doi: 10.1016/S0140-6736(17)31193-5. Epub 2017 May 7. Lancet. 2017. PMID: 28494920 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
